Silver Book Fact

Between August 2004 and July 2014, the FDA approved:

  • Six new anticancer therapeutics
  • Five new uses for previously approved anticancer therapeutics
  • Two new uses for imaging agents
  • One new use for a screening test

AACR Cancer Progress Report 2014. Clin Cancer Res Web site. http://clincancerres.aacrjournals.org/content/20/19/4977.full. Published 2014

Reference

Title
AACR Cancer Progress Report 2014
Publication
Clin Cancer Res
Publication Date
Published 2014
Authors
American Association for Cancer Research
Volume & Issue
Volume 20, Issue S1
Pages
S1-S112
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung…  
  • If the 1 million surgical breast biopsies performed annually were instead performed using image-guided needle core biopsy, the total savings could be $1.6 billion a year.  
  • The overall five-year survival rate for men with prostate cancer is 99 percent—up from 43 percent in 1975.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • For women age 40 or older, timely mammograms could reduce breast cancer mortality by about 16%–compared to those who are not screened.